2025-05-14T14:54:52-05:00 2024-06-30 991856619 GRANT THORNTON ADVISORS LLC 5955 TG LEE BLVD SUITE 200 ORLANDO FL 32822 990 2023-07-01 923388291 MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION MOFF 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 JOANNA WEISS EVP/CFO 8137451188 2025-05-14 1 0 MICHELE N MELCHIOR P00488037 4074815100 2023 2025-03-06 01:10:19Z JOSHUA CARPENTER 12902 MAGNOLIA DRIVE TAMPA FL 33612 4272805 0 X WWW.SPEROSFL.ORG X 2023 FL TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER. 4 4 8 4 0 0 0 4224805 0 0 0 0 0 48000 0 4272805 0 5050 0 0 0 1500847 0 0 0 0 2795905 0 4301802 0 -28997 0 0 0 122610 0 -122610 TO SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., WHOSE MISSION IS TO CONTRIBUTE TO A CURE FOR CANCER, BY BEING AN INTEGRAL PART IN DEVELOPING A 775-ACRE CAMPUS LOCATED IN PASCO COUNTY, FL. 0 0 5050 5050 MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION WILL BE THE GROUND LESSEE OF THE 775 ACRE CAMPUS LOCATED IN PASCO COUNTY, FL (THE "PROPERTY") WHICH IS CURRENTLY UNDER DEVELOPMENT INTO A GLOBAL LIFESCIENCES AND RESEARCH INNOVATION CAMPUS KNOWN AS "SPEROS FL" THROUGH WHICH THE CORPORATION WILL PARTNER WITH PUBLIC AND PRIVATE, EDUCATIONAL, BIOTECH, PHARMACEUTICAL, HEALTHCARE, AND OTHER ORGANIZATIONS TO SUPPORT AND ACCELERATE LIFESCIENCES RESEARCH AND CANCER CARE AND ADVANCE CUTTING-EDGE RESEARCH, TECHNOLOGIES, AND TREATMENT REGIMENS THAT WILL FURTHER THE INSTITUTE'S CHARITABLE MISSION OF TREATING AND CURING CANCER. 5050 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 14 0 1 8 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 1 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 X JOANNA WEISS 8137451188 12902 MAGNOLIA DRIVE TAMPA FL 33612 X YVETTE M LYONS TREMONTI CFO TO 5/17/24 6.00 50.00 X 0 1042682 397146 L DAVID DE LA PARTE PRESIDENT TO 6/11/24 6.00 50.00 X 0 865274 392072 SARABDEEP SINGH PRESIDENT AS OF 6/12/24 15.00 40.00 X 0 872462 120699 JOANNA WEISS CFO AS OF 5/19/24 6.00 49.00 X 0 528314 191655 CHARLES FLETCHER GENERAL COUNSEL 10.00 46.00 X 0 420464 131647 HENRY REYES VP FIN & CCO TO 4/1/24 20.00 35.00 X 203176 200263 72652 JOHN ALLGEIER VP RE DEV, CONS, OP AS OF 5/1/24 45.00 10.00 X 139481 189005 173547 MARTHA TRUSLOW LANAHAN CHAIR, DIRECTOR 1.00 0.00 X X 0 0 0 MARK METHANY VICE CHAIR, DIRECTOR 1.00 0.00 X X 0 0 0 TED COUCH SEC & TREAS, DIRECTOR 1.00 0.00 X X 0 0 0 EDISON LIU DIRECTOR 1.00 1.00 X 0 0 0 342657 4118464 1479418 2 0 1 0 SHUMAKER LOOP & KENDRICK LLP 1000 JACKSON ST TOLEDO OH 43604 LEGAL SERVICES 852535 PURE PROJECT MANAGEMENT LLC 2926 RICHMOND ST PHILADELPHIA PA 19134 PROJECT MANAGEMENT SRVCS 219803 SAVILLS INC 399 PARK AVE FL 11 NEW YORK NY 10022 CONSULTING SERVICES 176360 HR&A ADVISORS INC 99 HUDSON ST 3RD FLOOR NEW YORK NY 10013 CONSULTING SERVICES 111096 4 4224805 4224805 48000 0 48000 48000 48000 4272805 0 0 48000 X 5050 5050 689422 689422 734405 734405 7262 7262 14625 14625 55133 55133 659021 659021 1976291 1976291 42398 42398 87058 87058 17928 17928 10775 10775 DUES & SUBSCRIPTIONS 1500 1500 PROFESSIONAL DEVELOPMEN 795 795 CATERING & FOOD 139 139 4301802 5050 4296752 0 0 0 122610 0 122610 X -122610 0 0 -122610 0 0 X -28997 -93613 X 0 1 X 1 0 X X X 2 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 592451713 7 1 0 4296752 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL INC 593238634 3 0 0 0 2 0 4296752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 PART I, LINE 12G, COLUMN (VI) AMOUNTS REPORTED AS MONETARY SUPPORT ON SCHEDULE A, PART I, LINE 12G, COLUMN (VI) TO H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS COMPRISED OF EXPENSES INCURRED TO MANAGE THE PROPERTY AND SUPPORT OF THE INSTITUTE'S MISSION TO TREAT AND CURE CANCER. PART IV, LINE 1 THE ARTICLES OF INCORPORATION OF MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION (LIFESCIENCES) STATES THAT IT SHALL SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (THE INSTITUTE) AND ITS RELATED TAX EXEMPT ENTITIES. AS SUCH, LIFESCIENCES SUPPORTS THE INSTITUTE AS WELL AS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC., A RELATED TAX-EXEMPT ENTITY OF THE INSTITUTE AND WILL SUPPORT ANY FUTURE RELATED ORGANIZATIONS OF THE INSTITUTE, AS NECESSARY. PART IV, LINE 6 LIFESCIENCES MAY AT TIMES MAKE CONTRIBUTIONS TO OTHER PUBLIC CHARITIES WITHIN THE SURROUNDING COMMUNITY. THESE CONTRIBUTIONS WOULD BE MADE FULLY IN SUPPORT OF THE INSTITUTE AND DIRECTLY RELATED TO DEVELOPING AND MANAGING THE SPEROS PROPERTY TO FURTHER THE INSTITUTE'S MISSION TO TREAT AND CURE CANCER. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X PART X, LINE 2: MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION DID NOT HAVE ANY UNCERTAIN POSITIONS IN ITS AUDITED FINANCIAL STATEMENTS. THE ASC-740 FOOTNOTE READS AS FOLLOWS: SIGNIFICANT JUDGMENT IS REQUIRED TO EVALUATE UNCERTAIN TAX POSITIONS. THE CANCER CENTER EVALUATES ITS UNCERTAIN TAX POSITIONS ON A REGULAR BASIS. ITS EVALUATIONS ARE BASED ON A NUMBER OF FACTORS, INCLUDING CHANGES IN FACTS AND CIRCUMSTANCES, CHANGES IN TAX LAW, AND CORRESPONDENCE WITH TAX AUTHORITIES. THE CANCER CENTER ACCOUNTS FOR UNCERTAIN TAX POSITIONS BY RECOGNIZING A TAX BENEFIT OR LIABILITY AT THE LARGEST AMOUNT THAT, IN ITS JUDGMENT, IS MORE THAN 50% LIKELY TO BE REALIZED OR PAID BASED UPON TECHNICAL MERITS OF THE POSITION. THE CANCER CENTER CURRENTLY HAS NO TAX BENEFITS OR LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. 0 1 0 0 0 1 1 0 0 YVETTE M LYONS TREMONTI CFO TO 5/17/24 0 772296 0 212568 0 57818 0 362337 0 38529 0 1443548 0 0 L DAVID DE LA PARTE PRESIDENT TO 6/11/24 0 643431 0 178715 0 43128 0 365841 0 29834 0 1260949 0 0 SARABDEEP SINGH PRESIDENT AS OF 6/12/24 0 682357 0 185203 0 4902 0 87740 0 38053 0 998255 0 0 JOANNA WEISS CFO AS OF 5/19/24 0 407594 0 94914 0 25806 0 158381 0 36877 0 723572 0 0 CHARLES FLETCHER GENERAL COUNSEL 0 320442 0 75336 0 24686 0 98389 0 36519 0 555372 0 0 HENRY REYES VP FIN & CCO TO 4/1/24 125848 197280 75464 0 1864 2983 38733 12214 10756 17176 252665 229653 0 0 JOHN ALLGEIER VP RE DEV, CONS, OP AS OF 5/1/24 104874 157580 33594 0 1013 31425 130191 12602 12222 19900 281894 221507 0 0 PART I, LINE 3 LIFESCIENCES RELIES ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, A RELATED ORGANIZATION WHICH USES AN INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEYS OR STUDIES, AN EXECUTIVE COMPENSATION COMMITTEE, AND THE APPROVAL BY THE BOARD OR THE EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD, TO ESTABLISH THE ORGANIZATION'S CEO, PRESIDENT, AND TOP MANAGEMENT OFFICIALS' COMPENSATION. PART I, LINE 4B TO BE ELIGIBLE TO PARTICIPATE IN THE 457(F) NON-QUALIFIED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP), PARTICIPANTS MUST ELECT TO CONTRIBUTE AT LEAST 10% ACROSS THE 403(B) AND 457(B) PLANS, AND ARE VESTED AFTER 10 YEARS OF SERVICE. LUMP SUM DISTRIBUTIONS FROM THE ACCOUNT ARE MADE UPON NORMAL RETIREMENT OR TERMINATION. BELOW ARE INDIVIDUALS LISTED ON LIFESCIENCES' 2023 FORM 990 PART VII, SECTION A, THAT PARTICIPATED IN THE 457(F) SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND THEIR RESPECTIVE AMOUNTS OF COMPENSATION CONSTRUCTIVELY RECEIVED IN TAX YEAR 2023 FROM THE PLAN: L. DAVID DE LA PARTE - $32,791 YVETTE M. TREMONTI - $ 45,116 CHARLES FLETCHER - $0 SARABDEEP SINGH - $0 JOANNA WEISS - $24,396 PART I, LINE 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON MOFFITT CANCER CENTER'S ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS RELATED TO NET OPERATING INCOME AND ON DIVISION OR INDIVIDUAL GOALS. NET OPERATING INCOME MUST MEET OR EXCEED A CERTAIN THRESHOLD IN ORDER TO TRIGGER A PAYOUT FOR THE ORGANIZATIONAL GOAL COMPONENTS. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION ("LIFESCIENCES") AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. LIFESCIENCES & MOFFITT TECHNOLOGIES CORPORATION (MTC): L. DAVID DE LA PARTE - LIFESCIENCES OFFICER; MTC OFFICER YVETTE M. LYONS TREMONTI - LIFESCIENCES OFFICER; MTC OFFICER CHARLES FLETCHER-LIFESCIENCES OFFICER; MTC OFFICER FORM 990, PART VI, SECTION A, LINE 6 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. ("THE INSTITUTE") IS THE SOLE MEMBER OF MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION ("LIFESCIENCES"). FORM 990, PART VI, SECTION A, LINE 7A AS THE SOLE MEMBER OF LIFESCIENCES, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. ("THE INSTITUTE") SHALL HAVE THE POWER TO APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF LIFESCIENCES. FORM 990, PART VI, SECTION A, LINE 7B THE SOLE MEMBER OF THE CORPORATION SHALL BE THE INSTITUTE, WHICH SHALL HAVE THE FOLLOWING POWERS: A) APPROVE, DISAPPROVE, OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE ARTICLES OF INCORPORATION OF THE CORPORATION; B) APPROVE, DISAPPROVE, OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE BYLAWS OF THE CORPORATION; C) APPROVE, DISAPPROVE, OR RECOMMEND THE SELECTION OF A QUALIFIED AUDIT FIRM AND THE ANNUAL OPERATING AND CAPITAL BUDGET OF THE CORPORATION; D) APPROVE OR DISAPPROVE THE TRANSFER, SALE, LEASE OR DISPOSITION OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS OF THE CORPORATION IN EXCESS OF THE DOLLAR THRESHOLD SET FORTH BY BOARD APPROVED POLICY; E) APPROVE OR DISAPPROVE THE CONFERRING OF ANY LIEN OR SECURITY INTEREST IN ASSETS OF THE CORPORATION IN EXCESS OF THE DOLLAR THRESHOLD SET FORTH BY BOARD APPROVED POLICY, WHETHER SAME SHALL BE IN CONNECTION WITH EITHER PUBLIC OR PRIVATE FINANCING, OR OTHERWISE; F) APPROVE OR DISAPPROVE ALL DONATIONS OR CHARITABLE CONTRIBUTIONS BY THE CORPORATION IN EXCESS OF THE DOLLAR THRESHOLD SET FORTH BY BOARD APPROVED POLICY PER CONTRIBUTION OR IN THE AGGREGATE; G) APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION OF THE CORPORATION'S MISSION AND PHILOSOPHY STATEMENT; H) APPROVE OR DISAPPROVE CAPITAL EXPENDITURES BY THE CORPORATION IN EXCESS OF THE DOLLAR THRESHOLD SET FORTH BY BOARD APPROVED POLICY PER EXPENDITURE OR IN THE AGGREGATE ANNUALLY; AND I) APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OR OFFICER OF THE CORPORATION. FORM 990, PART VI, SECTION A, LINE 8B LIFESCIENCES DOES NOT HAVE A COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B PRIOR TO ELECTRONICALLY FILING FORM 990 (RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX), A COPY OF THE RETURN IS PROVIDED TO THE JOINT FINANCE COMMITTEE, CONSISTING OF BOARD MEMBERS ACROSS THE CANCER CENTER, GIVING EACH MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. LIFESCIENCES' FORM 990 IS ALSO PROVIDED TO THE CHIEF FINANCIAL OFFICER FOR REVIEW. BASED ON THE REVIEW ANY SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED, AND IF DEEMED NECESSARY CHANGES ARE MADE PRIOR TO SIGNING. FORM 990, PART VI, SECTION B, LINE 12C H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., THE INSTITUTE AND PARENT ORGANIZATION OF THE CANCER CENTER, DEVELOPS, IMPLEMENTS, AND ENFORCES COMPANY POLICY FOR THE CANCER CENTER AS A WHOLE. ON AN ANNUAL BASIS A PRESENTATION IS MADE TO ALL BOARD MEMBERS THROUGHOUT MOFFITT'S ENTITIES, INCLUDING LIFESCIENCES' BOARD MEMBERS, TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE CERTIFICATION VIA THE ELECTRONIC DISCLOSURE SYSTEM. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE ELECTRONIC FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 THE INSTITUTE HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE COMMITTEE MEMBERS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE COMPENSATION OF MOFFITT DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, CHIEF HUMAN RESOURCES OFFICER, CHIEF ENTERPRISE RISK OFFICER, VP FINANCE, VP MOFFITT MEDICAL GROUP, VP PATIENT CARE SERVICES/CHIEF NURSING OFFICER AND VP CHIEF PHARMACY OFFICER. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN, AS NEEDED, AND DOES AT ITS DISCRETION, ENGAGE INDEPENDENT OUTSIDE ADVISORS, INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND THIRD-PARTY COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD-PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH DISQUALIFIED PERSON. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE INSTITUTE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT, INCLUDING THE VALUE OF ALL BENEFITS AND PERQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE DISQUALIFIED PERSONS. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE DISQUALIFIED PERSON CATEGORY, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS, ALONG WITH THE CONSULTANT'S COMPARABILITY DATA, ARE PRESENTED TO THE JEC&BC FOR THE COMMITTEE MEMBERS TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE INSTITUTE BOARD. FORM 990, PART VI, SECTION C, LINE 19 ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND ARTICLES OF INCORPORATION AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A EMPLOYEES WHO ARE LISTED ON MOFFITT LIFESCIENCES' FORM 990 ARE EMPLOYEES WHOSE W-2'S WERE ISSUED BY MOFFITT INSTITUTE, THE COMMON PAYMASTER AND RELATED ENTITY. PROCEDURES TO REPORT COMPENSATION OF EMPLOYEES ON FORM 990 PART VII AND ON SCHEDULE J ARE IN ACCORDANCE WITH IRS INSTRUCTIONS FOR EACH RESPECTIVE SECTION. FORM 990, PART IX, LINE 11G CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 1,952,154. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,952,154. MISCELLANEOUS PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 13,619. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 13,619. LANDSCAPING SERVICES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 10,518. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 10,518. FORM 990, PART XI, LINE 9 CHANGES IN NET ASSETS PREDOMINANTLY RELATES TO THE CLOSE OUT OF INTERCOMPANY ACCOUNTS PAYABLE AND RECEIVABLE (DUE TO/DUE FROM) IN THE AMOUNT OF $-93,613 TO NET ASSETS. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) LINE 7 H LEE MOFFITT CC&RI INC 0 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) LINE 3 H LEE MOFFITT CC&RI INC 0 H LEE MOFFITT CC& RI LIFETIME CANCER SCREENING CENTER INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238640 PRACTICE MANAGEMENT FL 501(C)(3) LINE 10 H LEE MOFFITT CC&RI INC 0 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 PARENT-RESEARCH FL 501(C)(3) LINE 7 N/A 0 MOFFITT REAL ESTATE HOLDING CORP 12902 MAGNOLIA DRIVE TAMPA FL 33612 923387708 HOLDING TITLE FL 501(C)(2) N/A H LEE MOFFITT CC&RI INC 0 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL N/A C 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0